These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies. Rosano TG; Pell MA; Freed BM; Dybas MT; Lempert N Transplant Proc; 1988 Apr; 20(2 Suppl 2):330-8. PubMed ID: 3284076 [No Abstract] [Full Text] [Related]
4. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine. Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466 [No Abstract] [Full Text] [Related]
5. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy. Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444 [No Abstract] [Full Text] [Related]
6. The influence of renal allograft function upon cyclosporine blood levels. Arnold AN; Chang TW; Miura S; Rapaport FT Transplant Proc; 1987 Feb; 19(1 Pt 2):1240-1. PubMed ID: 3274309 [No Abstract] [Full Text] [Related]
7. The effects of donor specific transfusion and cyclosporine A on graft outcome. Haberal M; Oner Z; Aybasti N; Arslan G; Turan M; Bilgin N Transplant Proc; 1987 Feb; 19(1 Pt 3):2269-70. PubMed ID: 3274506 [No Abstract] [Full Text] [Related]
8. Renal transplantation from living donors mismatched for two HLA haplotypes. Sødal G; Albrechtsen D; Berg KJ; Bondevik H; Brekke IB; Fauchald P; Jakobsen A; Talseth T; Thorsby E; Flatmark A Transplant Proc; 1987 Feb; 19(1 Pt 2):1509-10. PubMed ID: 3079022 [No Abstract] [Full Text] [Related]
9. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression. Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483 [No Abstract] [Full Text] [Related]
10. Glomerular rejection in kidney allografts under cyclosporin. Onitsuka S; Yamaguchi Y; Toma H; Yagisawa T; Takahashi K; Teraoka S; Ota K Transplant Proc; 1989 Feb; 21(1 Pt 2):1680-2. PubMed ID: 2652550 [No Abstract] [Full Text] [Related]
11. Alternative immunosuppressive strategies in the management of recipients of living related renal transplants. Hodge E; Banowsky L; Novick A; Lewis R; Streem S; Steinmuller D; Holzmann J; McFarlin L; Graneto D; Medendorp SV Transplant Proc; 1989 Feb; 21(1 Pt 2):1609-14. PubMed ID: 2652524 [No Abstract] [Full Text] [Related]
12. Effect of HLA matching supersedes many others for long-term cadaver kidney transplants. Milgrom M; Gomez C; Esquenazi V; Olson L; Roth D; Miller J Transplant Proc; 1989 Feb; 21(1 Pt 1):675-6. PubMed ID: 2650218 [No Abstract] [Full Text] [Related]
13. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy. Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841 [No Abstract] [Full Text] [Related]
14. Effects of azathioprine, cyclosporine, and steroids on the graft and on cytologic patterns of rejection. Häyry P; von Willebrand E; Ahonen J; Eklund B; Salmela K; Höckerstedt K; Pettersson E; Koskimies S Transplant Proc; 1987 Feb; 19(1 Pt 2):1650-1. PubMed ID: 3079031 [No Abstract] [Full Text] [Related]
15. Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression. Raine AE; Carter R; Mann JI; Chapman JR; Morris PJ Transplant Proc; 1987 Feb; 19(1 Pt 2):1820-1. PubMed ID: 3274428 [No Abstract] [Full Text] [Related]